Global Fellowship Program

Advance New and Innovative Research

Guided by our vision, the USP Global Fellowship Program presents awards to doctoral and post-doctoral students to advance new research contributing to innovative or updated quality standards for chemical and biological medicines, excipients, dietary supplements, herbal medicines, healthcare quality, and food ingredients. Since the program's inception in 1981, USP has invested nearly $4 million in more than 200 Fellowship awards. 

2016-2017 Fellowship Applications Now Being Accepted

Application deadline for 2016-2017 fellowships is October 28, 2016.


Research Priorities

Applicants are encouraged to ensure their research aligns with one of these topics:

General Research

  • Modernization of monographs (analytical methods): assessment and prioritization of needs, implementation.
  • Particle characterization technologies that could lead to general chapter additions/improvements and/or methods for monograph use.
  • Spectroscopic techniques combined with chemometric approaches for counterfeit and fraud detection.
  • Creation of new topical/dermal dosage formulations as use for reference materials suitable for in vitro apparatus performance verification testing.
  • Continuous Manufacturing: New technologies for both material characterization and advanced analytical testing in support of in-process control and real time release testing (RTRT).
  • Nanomedicines: New analytical technologies applicable to the measurement of quality attributes and performance tests.
  • Characterization of the composition of gastrointestinal fluids in animal species. 
  • General Chapter technique relevance to global health monographs.
  • eHealth (digital health) related technology development that enhances healthcare quality.
  • Novel development in emerging pharmaceutical manufacturing technologies including 3-D printing.
  • Precision medicine (personalized medicine) related novel development research.
  • Quantitative NMR technology.
  • DNA based identification technology.
  • Novel advanced analytical technologies for on-line analyses and/or portable comprehensive analysis.

Chemical Medicines

  • Development of analytical method(s) for the analysis of inorganic species in drug products and drug substances (similar to what is described in General Chapter <191> Identification Tests—General).
  • Development and validation of orthogonal identification test in drug substance and drug products.
  • Development of performance (e.g., dissolution) test procedures for OTC products.
  • Development of impurity procedures to fully characterize impurities in drug substance and drug products.
  • Replacement of microbial assay with HPLC method.
  • Modernization of monographs-method development validation (replacing titration with HPLC or replacing wet chemistry procedures with chromatography or other instrumental techniques).
  • Development and validation of LC-MS or GC-MS procedures for the analysis of genotoxic impurities.
  • Use of mass spectrometric analysis of high-throughput screening of small molecule drug products.

Biologics and Biotechnology

  • Flow cytometry in biological applications that could lead to general chapter additions/improvements and/or methods for monograph use.
  • Purity assessment (protein concentration determination assays).
  • Methods to revise the protein content determination and purity assessment.
  • Use of molecular biology techniques for species identification for wheat or other food-based components.
  • Higher order structure characterization for complex materials/molecules.
  • Modernization of activity assays, especially enzymatic assays.
  • Bridging product-specific bioassays.
  • Development and validation of analytical methods for characterization of vaccines.


  • Development of rheological methods for the effective characterization of excipients, hydroxyethyl cellulose and carboxymethyl cellulose sodium.
  • Development and validation of orthogonal identification test(s) for excipients.
  • Development and validation of analytical method(s) for excipients used in B&B drugs.
  • Development of procedures that can be used to qualify excipients in a QC setting and determine if fit for intended pharmaceutical purpose (e.g., investigate the use of low field NMR as a new tool for the identity testing of excipients.)
  • Development and validation of analytical method(s) for nanotechnology derived excipients.
  • Development and validation of authentication/identification and quantitative assay/purity methods that can discriminate adulterated from non-adulterated materials for pharmaceutical components at risk for intentional adulteration.
  • Development and validation of a predictive model to help identify excipients vulnerable to intentional adulteration.
  • Molecular weight distribution determination for water soluble polymeric excipients by SEC/MALS.
  • Advanced macromolecular excipient characterization to decrease variability in USP excipient standards.

Dietary Supplements

  • Establishment of advanced analytical methodologies for characterization of complex biopolymeric constituents of dietary supplements.
  • “Electronic reference”: concept development and software-driven implementation in pharmacopeial context.
  • Integration of chemometric analysis into identification schemes suitable for implementation within pharmacopeial monographs.
  • “Big data” use in compendial analysis: custom software solutions to authentication based on collating of numerous streams of analytical data.
  • Practical implementation of DNA-based analysis in supplements derived from plant or animal sources, and its compendial use.
  • Development of performance standards for dietary supplement in gummies.
  • Application of databases to compendial tests: Development of methods for sample data comparison with references housed in databases and setting acceptance criteria.

Food Ingredients

  • Development  and validation of new tools for assessing risks for food ingredient supply chains to food fraud such as:
    • Case studies or meta-analysis on the implementation and validation of food fraud vulnerability assessment and mitigation tools.
    • Research to develop and validate economic anomaly models for anticipating food fraud vulnerabilities.
  • Research into global industry and consumer trends for food ingredients to inform future directions and needs for USP standards in line with USP’s public health mission.
  • Development and validation of analytical methods for the following areas:
    • Non-targeted methods for fraud/adulteration detection in fraud vulnerable ingredients.
    • DNA based methods for detecting fraud in protein-based food ingredients.
    • Development of new protein characterization/quantitation methods to help authenticate protein-based ingredients.
  • Single instrument/measurement approaches to chemical ID and quantitation of materials for food reference standards (e.g., low cost food reference materials/standards).

Healthcare Quality Standards

  • Healthcare Information Technology (HIT) and value to risk reduction in the healthcare environment
    • Characterize, quantify and prioritize medication safety issues occurring within electronic health environments.
    • “Big data” analytics utilization in the prevention and reduction of medication errors.
  • Translation and implementation of published USP Compounding and Hazardous Drugs Standards
    • Development of innovative educational strategies to ensure practitioner competency with performance of sterile procedures as described by USP <797> (e.g., simulated training, video training library, observation and training venues).
    • Development of best practices of implementation of USP compounding standards within in-patient settings, including hospitals, long-term care facilities and nursing homes.
  • Advancements in Healthcare Quality and Safety
    • Definition of the risk of healthcare associated infections (HAI) in compounding practice.
    • The development of continuous quality improvement tools to support reduction of healthcare associated infections (HAI) related to medication preparation and administration practices.
    • Antibiotic stewardship: Quantification of the challenge, and draft ‘standard’ for judicious use of antibiotics.
  • Modernization of Nomenclature and Labeling
    • Advances in electronic indexing and digital information of chemical information and compound structure.
    • Optimization and standardization of labeling nomenclature in compendial monographs.


Applicants must:
  • Have been accepted for full-time study in a Ph.D. or Pharm.D. program, or medical or dental school; or
  • Have been awarded a postdoctoral research (non-faculty) appointment.
Non-U.S. applicants must have a background in standards and currently be enrolled in an equivalent educational program. International students must possess the appropriate visa required to participate in the Global Fellowship Program. USP will not assist students to obtain a visa for this purpose. USP may require proof of visa status as a condition of offering a Fellowship to a student.
Applicants for Global Fellowships may not currently be in receipt of funds from USP, or directly or indirectly under contract with USP, even if the activity is unrelated to the applicant’s research proposal.

Selection Process

  • Applications are reviewed by a USP internal selection group composed of senior scientific staff.
  • Each proposal's significance is ranked on how closely it addresses a specific area of USP research.


Contact Linda Stelling, Program Coordinator, International Regulatory Affairs, at